Trump pharmaceutical policy may help raise Canadian drug prices to American levels

A statement from Donald Trump’s health reform proposal poses a potential problem for Canadians:Remove barriers to entry into free markets for drug providers that offer safe, reliable and cheaper products. Congress will need the courage to step away from the special interests and do what is right for America. Though the pharmaceutical industry is in the private sector, drug companies provide a public service. Allowing consumers access to imported, safe and dependable drugs from overseas will bring more options to consumers.Mr. Trump is not hostile to pharmaceutical innovation. In his 100-day plan, he promised “reforms will also include cutting the

Read More - The Fraser Institute